Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bias in research and conflict of interest: why should we care?

Literature DB >> 17120173

Bias in research and conflict of interest: why should we care?

H P Dietz¹.

Abstract

Mesh：

Year: 2006 PMID： 17120173 DOI： 10.1007/s00192-006-0236-1

Source DB: PubMed Journal: Int Urogynecol J Pelvic Floor Dysfunct

× No keyword cloud information.

22 in total

1. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors: Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal: JAMA Date: 2002-02-06 Impact factor: 56.272

2. Physician-industry relations. Part 1: individual physicians.

Authors: Susan L Coyle
Journal: Ann Intern Med Date: 2002-03-05 Impact factor: 25.391

3. Lotronex and the FDA: a fatal erosion of integrity.

Authors: R Horton
Journal: Lancet Date: 2001-05-19 Impact factor: 79.321

Review 4. The making of a disease: female sexual dysfunction.

Authors: Ray Moynihan
Journal: BMJ Date: 2003-01-04

5. Alosetron for irritable bowel syndrome.

Authors: Michel Lièvre
Journal: BMJ Date: 2002-09-14

6. The ethics of pharmaceutical industry relationships with medical students.

Authors: Wendy A Rogers; Peter R Mansfield; Annette J Braunack-Mayer; Jon N Jureidini
Journal: Med J Aust Date: 2004-04-19 Impact factor: 7.738

Review 7. Industry sponsorship and authorship of clinical trials over 20 years.

Authors: Susan S Buchkowsky; Peter J Jewesson
Journal: Ann Pharmacother Date: 2004-02-24 Impact factor: 3.154

8. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors: Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal: CMAJ Date: 2004-02-17 Impact factor: 8.262

Bias in research and conflict of interest: why should we care?

1. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

2. Physician-industry relations. Part 1: individual physicians.

3. Lotronex and the FDA: a fatal erosion of integrity.

Review 4. The making of a disease: female sexual dysfunction.

5. Alosetron for irritable bowel syndrome.

6. The ethics of pharmaceutical industry relationships with medical students.

Review 7. Industry sponsorship and authorship of clinical trials over 20 years.

8. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

9. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.

10. Principles for strengthening the integrity of clinical research.

1. Urogynaecological research: current and future developments.

2. Authors should publish their raw data.

3. Disclosures, conflict of interest, and funding issues in urogynecology articles: a bibliometric study.